Hydrochlorothiazide
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Hydrochlorothiazide (HCTZ) is a thiazide diuretic and one of the most commonly prescribed antihypertensives. It is often used in combination with other agents including ACE inhibitors, ARBs, and potassium-sparing diuretics. Despite widespread use, recent evidence suggests chlorthalidone may offer superior 24-hour BP control.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Hydrochlorothiazide (HCTZ) is a thiazide diuretic and one of the most commonly prescribed antihypertensives. NutriStack rates the supporting evidence as strong. Common adult dosing is 12.5–50 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete potassium, magnesium, zinc. This profile indexes 10 sources.
- Hypokalemia
- Hyponatremia
- Hyperuricemia and gout flares
- Anuria
- Hypersensitivity to HCTZ or sulfonamide-derived drugs
The bottom line
Evidence rating strong. Most-documented uses: effective blood pressure reduction, reduces risk of stroke and cardiovascular events in hypertensive patients, low cost and widely available. 10 sources indexed (2012–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits the sodium-chloride cotransporter (NCC) in the distal convoluted tubule of the nephron. Reduces sodium and chloride reabsorption, increasing urine output and reducing plasma volume. Long-term blood pressure reduction is thought to involve decreased peripheral vascular resistance via mechanisms not fully understood.
Dosing & protocol.
Can be taken with or without food; take in the morning to avoid nocturia1
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Potassium
ModerateThiazide diuresis can increase distal sodium delivery and urinary potassium secretion, so potassium should be monitored rather than self-repleted.
Magnesium
ModerateThiazides can increase urinary magnesium losses and contribute to low magnesium status.
Zinc
MildChronic thiazide use can increase urinary zinc excretion and gradually lower zinc balance.
Sodium
ModerateThiazides are a common medication cause of hyponatremia, especially in older adults.
CoQ10
MildBeta-blocker and diuretic therapy are associated with lower CoQ10 status in some long-term users, likely through increased oxidative demand and reduced tissue levels.
Full safety detail.
Side effects
- Hypokalemia
- Hyponatremia
- Hyperuricemia and gout flares
- Hyperglycemia
- Hyperlipidemia
- Dizziness and orthostatic hypotension
- Photosensitivity
- Erectile dysfunction
Contraindications
- Anuria
- Hypersensitivity to HCTZ or sulfonamide-derived drugs
- Severe renal impairment (eGFR <30 mL/min, limited efficacy)
- Hypokalemia or hyponatremia (uncorrected)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-AnalysisPMIDCicero AFG, ALGhasab NS, Tocci G et al. · Journal of clinical medicine · 2024
Cicero AFG, ALGhasab NS, Tocci G et al.. Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis. Journal of clinical medicine. 2024
- 2Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-AnalysisPMIDKhenhrani RR, Nnodebe I, Rawat A et al. · Cureus · 2023
Khenhrani RR, Nnodebe I, Rawat A et al.. Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis. Cureus. 2023
- 3Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-AnalysisPMIDKumar L, Khuwaja S, Kumar A et al. · Cureus · 2023
Kumar L, Khuwaja S, Kumar A et al.. Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis. Cureus. 2023
- 4[Hydrochlorothiazide use and risk of skin cancers: A systematic review]PMIDBecquart O, Guillot B, Bourrain JL et al. · La Revue de medecine interne · 2019
Becquart O, Guillot B, Bourrain JL et al.. [Hydrochlorothiazide use and risk of skin cancers: A systematic review]. La Revue de medecine interne. 2019
- 5Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analysesPMIDRoush GC, Holford TR, Guddati AK · Hypertension (Dallas, Tex. : 1979) · 2012
Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension (Dallas, Tex. : 1979). 2012
Reference material
5- 6ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA. 2002.Source linkedPMID
- 7Ernst ME et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006.Source linkedPMID
- 8Singh A et al. Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis. J Hum Hypertens. 2026.Source linkedPMID
- 9Dineva S, Uzunova K, Pavlova V et al.. Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis. Journal of human hypertension. 2019Source linkedPMID
- 10Ernst ME, Fravel MA. Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide. American journal of hypertension. 2022Source linkedPMID
Common questions.
Quick answers about Hydrochlorothiazide, drawn from the data on this page.
What is Hydrochlorothiazide?
Hydrochlorothiazide (HCTZ) is a thiazide diuretic and one of the most commonly prescribed antihypertensives. It is often used in combination with other agents including ACE inhibitors, ARBs, and potassium-sparing diuretics. Despite widespread use, recent evidence suggests chlorthalidone may offer superior 24-hour BP control.
What is Hydrochlorothiazide used for?
Commonly cited benefits of Hydrochlorothiazide include: Effective blood pressure reduction; Reduces risk of stroke and cardiovascular events in hypertensive patients; Low cost and widely available; Synergistic with ACE inhibitors and ARBs. NutriStack rates the overall evidence as strong.
What is a typical dose of Hydrochlorothiazide?
A typical adult dose of Hydrochlorothiazide is 12.5–50 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet or capsule. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Hydrochlorothiazide?
Reported side effects include hypokalemia, hyponatremia, hyperuricemia and gout flares, hyperglycemia, hyperlipidemia, dizziness and orthostatic hypotension. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Hydrochlorothiazide?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Hydrochlorothiazide in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.